Thu Jan 30 08:22:02 UTC 2025: ## Mixed Signals in Indian Markets: Dr. Agarwal’s IPO Underwhelms While Shapoorji Pallonji Seeks Debt Refinancing

**Mumbai, January 30, 2025** – India’s financial markets showed mixed signals today. The initial public offering (IPO) of Dr. Agarwal’s Health Care, a leading eye care provider, received a muted response on its second day, with a subscription rate of only 7%. Priced between Rs 382 and Rs 402 per share, the Rs 3,025 crore IPO has drawn caution from analysts like StoxBox, who cite overvaluation and inconsistent financial performance. While Anand Rathi Research gives a “subscribe for long-term” rating citing its dominant market share (approximately 25% of India’s eye care market), the IPO’s grey market premium (GMP) of only Rs 12 suggests limited investor enthusiasm. The company reported a net profit of Rs 39.56 crore on a revenue of Rs 837.94 crore for the six months ending September 30, 2024.

Meanwhile, the Shapoorji Pallonji Group is reportedly close to finalizing a deal to refinance its approximately $3.2 billion debt with global alternative asset investors. This follows a previous $2.6 billion loan secured in 2021.

In other news, CLN Energy’s shares were listed on the BSE SME platform at Rs 256, a 2.4% premium over its IPO price. The Traders Gurukul’s BOTS (India’s Largest Regional Retail Option Traders Summit) continues to provide insights into the dynamic crypto market, offering a platform for potential investors and brokers to connect. However, no significant trends were reported regarding the CLN Energy SME IPO grey market premium as of today. The article also briefly mentions a need for investors to decide between IT and Banking stocks, and provides links to various financial news and analysis.

Read More